Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regan Fulton

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
JCO Precision Oncology|July 16, 2025
Quantitative Multiplex Immunofluorescence Assay for Trophoblast Cell-Surface Antigen 2 and Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer: Toward Guiding Patient Selection for Antibody-Drug Conjugate TherapiesCharles J Robbins, Mengni He, Nay Chan, et al.
Molecular Cancer Therapeutics|April 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell CarcinomaMengni He, Ioannis P Trontzas, Katherine M Bates, et al.
Oncotarget|August 6, 2016
Novel antibody probes for the characterization of endosialin/TEM-1Daniel J O'Shannessy, Michael F Smith, Elizabeth B Somers, et al.
American Journal of Clinical Pathology|June 19, 2012
Immunohistochemistry cocktails are here to stay: Center for Medicare and Medicaid Services should revise its new reimbursement policyHadi Yaziji, Richard Eisen, Mark Wick, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 19, 2012
Immunohistochemistry cocktails are here to stay: Center of Medicare and Medicaid Services should revise its new reimbursement policyHadi Yaziji, Richard Eisen, Mark Wick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 2022
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancerMyrto Moutafi, Charles J Robbins, Vesal Yaghoobi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 19, 2026
Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-ScoreMengni He, Nay N N Chan, Matthew Liu, et al.
Archives of Pathology & Laboratory Medicine|February 23, 2024
Principles of Analytic Validation of Immunohistochemical Assays: Guideline UpdateJeffrey D Goldsmith, Megan L Troxell, Sinchita Roy-Chowdhuri, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 4, 2016
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung CancerBrandon S Sheffield, Regan Fulton, Steve E Kalloger, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JCO Precision Oncology|July 16, 2025
Quantitative Multiplex Immunofluorescence Assay for Trophoblast Cell-Surface Antigen 2 and Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer: Toward Guiding Patient Selection for Antibody-Drug Conjugate TherapiesCharles J Robbins, Mengni He, Nay Chan, et al.
Molecular Cancer Therapeutics|April 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell CarcinomaMengni He, Ioannis P Trontzas, Katherine M Bates, et al.
Oncotarget|August 6, 2016
Novel antibody probes for the characterization of endosialin/TEM-1Daniel J O'Shannessy, Michael F Smith, Elizabeth B Somers, et al.
American Journal of Clinical Pathology|June 19, 2012
Immunohistochemistry cocktails are here to stay: Center for Medicare and Medicaid Services should revise its new reimbursement policyHadi Yaziji, Richard Eisen, Mark Wick, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 19, 2012
Immunohistochemistry cocktails are here to stay: Center of Medicare and Medicaid Services should revise its new reimbursement policyHadi Yaziji, Richard Eisen, Mark Wick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 2022
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancerMyrto Moutafi, Charles J Robbins, Vesal Yaghoobi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 19, 2026
Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-ScoreMengni He, Nay N N Chan, Matthew Liu, et al.
Archives of Pathology & Laboratory Medicine|February 23, 2024
Principles of Analytic Validation of Immunohistochemical Assays: Guideline UpdateJeffrey D Goldsmith, Megan L Troxell, Sinchita Roy-Chowdhuri, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 4, 2016
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung CancerBrandon S Sheffield, Regan Fulton, Steve E Kalloger, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Pageof 2